SBIR/STTR Research Award
Blood-based test for Traumatic Brain Injury and Alzheimer’s Disease screening
Award amount
$74,886Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- AperionDx
- Proposal award date
- 2023-05-05
- Contract end date
- 2023-08-07
- UEI
- V427R2HF7GL2
- Solicitation number
- X23.5
- Topic code
- AFX235-CSO1
Research abstract
Traumatic Brain Injury (TBI) and Alzheimer's Disease (AD) are vast and growing health problems globally, and the main challenges are in the patients' early detection and improved care. Within the USAF, there is an increased risk of TBI and AD for active-d
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of a Semi-autonomous Handheld Robotic Device to Enable Rapid Vascular Access By Non-specialists in Austere Environments
- Evitado TACFI
- AI for Adaptive 3D Infrastructure Design in Navy Engineering
- Smart Thermal Protection Systems for Hypersonics
- Sub-THz Reflectarrays: An Alternative Architecture for Enhanced Array Scaling with 3D Heterogeneous Integration for DoD ELGAR Use Cases
Research funding history
2 SBIR/STTR records share this UEI (2023–2024). Reported award amounts total $1,324,820. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Defense